Finland was the first country to offer the zoonotic avian influenza A(H5N8) vaccine manufactured by Seqirus to at-risk occupational groups following the extensive clade 2.3.4.4b A(H5N1) outbreak ...

The study offers one of the most detailed maps yet of how human antibody responses vary from person to person.

Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...

Leveragen, Inc., a Boston-based biotechnology company advancing next-generation in vivo antibody discovery, announced today the issuance of a patent in Japan covering core innovations underlying its ...

Read more about Nanoparticle and AI-driven vaccines target broad protection against emerging threats on Devdiscourse ...